Revolution Medicines and EQRx Stockholders Approve EQRx Acquisition

REDWOOD CITY, Calif. and CAMBRIDGE, Mass., Nov. 08, 2023 -- Revolution Medicines, Inc. , a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, and EQRx, Inc. ,...

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,Chris Kittredge ,Hayley Cook ,Stephen Pettibone ,Eqrx Inc ,Nasdaq ,Globenewswire Inc ,Exchange Commission ,Revolution Medicines Inc ,Morrow Sodali ,Revolution Medicine ,Private Securities Litigation Reform Act ,Annual Reports ,Quarterly Reports ,Current Reports ,Revolution Medicine Quarterly Report ,Annual Report ,Joint Proxy ,Investor Relations ,Securities Act ,Media Contact ,Investor Contact ,Markets ,